{"id":"https://openalex.org/W2091999526","doi":"https://doi.org/10.1097/00002371-199104000-00008","title":"Interleukin-2 Lymphokine-Activated Killer Cell Therapy of Non-Hodgkin\u02bcs Lymphoma and Hodgkin\u02bcs Disease","display_name":"Interleukin-2 Lymphokine-Activated Killer Cell Therapy of Non-Hodgkin\u02bcs Lymphoma and Hodgkin\u02bcs Disease","publication_year":1991,"publication_date":"1991-04-01","ids":{"openalex":"https://openalex.org/W2091999526","doi":"https://doi.org/10.1097/00002371-199104000-00008","mag":"2091999526","pmid":"https://pubmed.ncbi.nlm.nih.gov/2043594"},"language":"en","primary_location":{"id":"doi:10.1097/00002371-199104000-00008","doi":"https://doi.org/10.1097/00002371-199104000-00008","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002371-199104000-00008","pdf_url":null,"source":{"id":"https://openalex.org/S177451610","display_name":"Journal of Immunotherapy","issn_l":"1524-9557","issn":["1524-9557","1537-4513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111955102","display_name":"Zale P. Bernstein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Z. P. Bernstein","raw_affiliation_strings":["Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263","Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":null,"display_name":"L. Vaickus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Vaickus","raw_affiliation_strings":["Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":null,"display_name":"N. Friedman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. Friedman","raw_affiliation_strings":["Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058087034","display_name":"Martin H. Goldrosen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. H. Goldrosen","raw_affiliation_strings":["Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008910767","display_name":"Haruki Watanabe","orcid":"https://orcid.org/0000-0001-7837-086X","observed_orcids":["https://orcid.org/0000-0001-7837-086X"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Watanabe","raw_affiliation_strings":["Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. Rahman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Rahman","raw_affiliation_strings":["Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109228194","display_name":"Susan G. Arbuck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. G. Arbuck","raw_affiliation_strings":["Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Sweeney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Sweeney","raw_affiliation_strings":["Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006880840","display_name":"Deborah Vesper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Vesper","raw_affiliation_strings":["Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":null,"display_name":"E. D. Henderson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. D. Henderson","raw_affiliation_strings":["Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025946569","display_name":"J. Zeffren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Zeffren","raw_affiliation_strings":["Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108391012","display_name":"R Dennin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. A. Dennin","raw_affiliation_strings":["Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072359954","display_name":"Dan Levitt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Levitt","raw_affiliation_strings":["Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073403338","display_name":"Kenneth A. Foon","orcid":"https://orcid.org/0000-0002-2748-0986","observed_orcids":["https://orcid.org/0000-0002-2748-0986"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. A. Foon","raw_affiliation_strings":["Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Clinical Immunology, Roswell Park Cancer Institute, Buffalo, New York","institution_ids":["https://openalex.org/I1292894508"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1292894508"],"apc_list":null,"apc_paid":null,"fwci":4.3742,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.94874624,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"2","first_page":"141","last_page":"146"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.6240000128746033,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.6240000128746033,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.30219998955726624,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.01899999938905239,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.9980000257492065},{"id":"https://openalex.org/keywords/lymphokine-activated-killer-cells","display_name":"lymphokine-activated killer cells","score":0.996999979019165},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9319999814033508},{"id":"https://openalex.org/keywords/hodgkin-lymphoma","display_name":"Hodgkin's disease","score":1.0},{"id":"https://openalex.org/keywords/adoptive-immunotherapy","display_name":"adoptive immunotherapy","score":0.8320000171661377},{"id":"https://openalex.org/keywords/continuous-intravenous-infusion","display_name":"continuous intravenous infusion","score":0.7799999713897705},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.7680000066757202},{"id":"https://openalex.org/keywords/disease-response","display_name":"disease response","score":0.5720000267028809},{"id":"https://openalex.org/keywords/relapsed-lymphoma","display_name":"relapsed lymphoma","score":0.5529999732971191}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8408108949661255},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.7612106800079346},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.7029985785484314},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6893184781074524},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.5687685608863831},{"id":"https://openalex.org/C2778476748","wikidata":"https://www.wikidata.org/wiki/Q1138590","display_name":"Non-Hodgkin's lymphoma","level":3,"score":0.5549745559692383},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4898073375225067},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4878859519958496},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4797835946083069},{"id":"https://openalex.org/C2777371288","wikidata":"https://www.wikidata.org/wiki/Q410130","display_name":"Interleukin 2","level":3,"score":0.4643543064594269},{"id":"https://openalex.org/C28651165","wikidata":"https://www.wikidata.org/wiki/Q4259786","display_name":"Lymphokine-activated killer cell","level":5,"score":0.4179459810256958},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.41560235619544983},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38903799653053284},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37690484523773193},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.17087745666503906},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.14566978812217712},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.0700015127658844},{"id":"https://openalex.org/C129374314","wikidata":"https://www.wikidata.org/wiki/Q909381","display_name":"Interleukin 21","level":4,"score":0.06340482831001282}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004341","descriptor_name":"Drug Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006689","descriptor_name":"Hodgkin Disease","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D015979","descriptor_name":"Killer Cells, Lymphokine-Activated","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00002371-199104000-00008","doi":"https://doi.org/10.1097/00002371-199104000-00008","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002371-199104000-00008","pdf_url":null,"source":{"id":"https://openalex.org/S177451610","display_name":"Journal of Immunotherapy","issn_l":"1524-9557","issn":["1524-9557","1537-4513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunotherapy","raw_type":"journal-article"},{"id":"pmid:2043594","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2043594","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of immunotherapy : official journal of the Society for Biological Therapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2057155778","https://openalex.org/W1889831449","https://openalex.org/W1991758715","https://openalex.org/W2036381781","https://openalex.org/W2267704758","https://openalex.org/W2154871491","https://openalex.org/W2013514207","https://openalex.org/W2482712737","https://openalex.org/W1592924232","https://openalex.org/W7214145525"],"abstract_inverted_index":{"We":[0],"conducted":[1],"a":[2,28,38],"phase":[3],"II":[4],"study":[5],"utilizing":[6],"interleukin-2":[7],"(IL-2)":[8],"with":[9,43,64],"lymphokine-activated":[10],"killer":[11],"(LAK)":[12],"cells":[13],"as":[14,37],"therapy":[15,74,83],"for":[16,144],"non-Hodgkin's":[17],"lymphoma":[18],"(NHL)":[19],"and":[20,52,103,116],"Hodgkin's":[21],"disease":[22,114],"(HD).":[23],"IL-2":[24],"was":[25,60,84],"given":[26],"at":[27],"fixed":[29],"dose":[30,78,97],"of":[31,82,109],"3":[32],"x":[33],"10(6)":[34],"U/m2/day":[35],"administered":[36],"24-h":[39],"continuous":[40],"intravenous":[41],"infusion":[42],"LAK":[44],"cells.":[45],"Nineteen":[46],"extensively":[47],"treated":[48],"patients":[49,88,100],"were":[50,54,68,94,123],"entered":[51],"15":[53],"evaluable.":[55],"In":[56],"general,":[57],"this":[58,135],"regimen":[59,136],"reasonably":[61],"well":[62],"tolerated":[63],"mild":[65],"toxicities":[66,92],"that":[67,93],"rapidly":[69],"reversible.":[70],"Patients":[71],"who":[72],"completed":[73],"did":[75],"so":[76],"without":[77],"attenuations.":[79],"However,":[80],"discontinuation":[81],"necessary":[85],"in":[86],"four":[87,112],"due":[89],"to":[90,127,140],"atypical":[91],"not":[95,124,138],"clearly":[96],"related.":[98],"Two":[99],"(one":[101],"NHL":[102,131],"one":[104],"HD)":[105],"had":[106,113,118],"partial":[107],"remissions":[108],"brief":[110],"duration,":[111],"stabilization,":[115],"seven":[117],"progressive":[119],"disease.":[120,146],"While":[121],"there":[122],"sufficient":[125],"numbers":[126],"evaluate":[128],"critically":[129],"any":[130],"or":[132],"HD":[133],"subtype,":[134],"does":[137],"appear":[139],"have":[141],"significant":[142],"activity":[143],"either":[145]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}